XML 14 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash Flows From Operating Activities    
Net loss $ (6,659,899) $ (16,474,688)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization expense 1,302,384 3,663,953
Bad debt expense (recovery) (143,774) 492,906
Gain on debt extinguishment 0 1,205,195
Equity based compensation expense 1,490,903 4,106,040
Warrant modification expense 0 152,244
Change in fair value of warrant liability 96,000 0
Amortization of debt discount and debt costs 1,346,280 499,031
Loss on loan amendment (193,355) 0
Impairment expense 0 4,420,539
Gain on sale of intangible assets 0 (250,000)
Change in fair value of earn-out liability 0 26,604
Factoring discount fee and interest 22,009 179,303
Changes in assets and liabilities:    
Decrease in accounts receivable 1,967,824 (1,492,093)
Decrease in accounts receivable - related parties 0 49,033
Investment in Marketable Securities (382,144) 0
Increase (decrease) in prepaid expenses and other current assets 95,623 253,149
Increase in accounts payable and accrued liabilities (18,489) (594,967)
Decrease in accounts payable and accrued liabilities - related parties 0 (163,672)
Deferred payroll taxes 0 (79,244)
(Decrease) increase in deferred revenue (65,371) (531,231)
Net cash used in operating activities (947,299) (6,948,288)
Cash Flows From Investing Activities:    
Capitalized software development costs 0 (1,325,491)
Proceeds from sale of intangible assets 0 1,050,000
Purchase of property and equipment 0 (74,606)
Net cash (used) in investing activities 0 (350,097)
Cash Flows From Financing Activities:    
Proceeds from notes 0 4,077,127
Proceeds from ERC advances 450,000 0
Repayment of ERC advances (450,000) 0
Issuance of common stock, net of equity issuance costs of $280,490 785,509 0
Purchase of preferred shares pursuant to recapitalization (80,000) 0
Payments of loans (668,478) (2,013,661)
Proceeds from factoring agreement 871,821 7,303,537
Repayments of factoring agreement (215,127) (3,705,876)
Gross proceeds from exercise of warrants 315,178 0
Net cash provided by financing activities 1,008,903 5,661,127
Net increase (decrease) in cash 61,604 (1,637,258)
Cash, beginning of year 946,804 2,584,062
Cash, end of year 1,008,408 946,804
Supplemental disclosures of cash flow information:    
Cash paid during the period for interest 323,141 256,648
Cash paid during the period for income taxes 0 0
Supplemental schedule of non-cash investing and financing activities:    
Accounts receivable owed under factoring agreement collected directly by factor 959,980 3,495,683
Purchase price measurement period adjustment to goodwill and accounts receivable 0 $ 35,644
Common shares issued to settle accrued liability   409,036
Debt discount on warrants granted with notes 0 $ 1,632,842
Deemed dividends 503,642 1,921,213
Offering costs as a result of modification of warrants to induce exercise 10,400 0
Financing of insurance premium 92,174 0
Debt Discount on loan amendment 50,000 0
Transfer of accrued interest to loan principal upon loan amendment $ 80,555 $ 0